ASPIRE‐FTD Study Update: A Phase 1/2 Clinical Study to Evaluate AVB‐101 in FTD with GRN Mutations
Preliminary data from the ongoing ASPIRE-FTD trial suggests a favorable safety profile for AVB-101 and the administration procedure. Recruitment is ongoing for the subsequent escalated dose cohort.
Authors
- Yi‐Ge Huang (ORCID: https://orcid.org/0000-0002-1034-1517)
- Marcin Ratajczak (ORCID: https://orcid.org/0000-0003-1072-8380)
- Gabriela Klodowska
- David L. Cooper (ORCID: https://orcid.org/0000-0001-6140-2028)
- Jane YC Chan
- Miroslaw Zabek
- Christopher M Powell
- Rachel Sartaj
Institutions
- Uniwersytecki Szpital Dziecięcy (PL)
- Górnośląskie Centrum Medyczne (PL)
- Euro-Centrum (PL)
- Euromedic (PL)
- Aviagen (United Kingdom) (GB)
Publication Details
- Journal
- Alzheimer s & Dementia
- Published
- 2025-12-01
- DOI
- https://doi.org/10.1002/alz70859_102193
- Primary Topic
- Amyotrophic Lateral Sclerosis Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00